» Articles » PMID: 36603035

Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma Cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses

Overview
Journal J Immunol
Date 2023 Jan 5
PMID 36603035
Authors
Affiliations
Soon will be listed here.
Abstract

Infection with the protozoan parasite Trypanosoma cruzi elicits substantial CD8+ T cell responses that disproportionately target epitopes encoded in the large trans-sialidase (TS) gene family. Within the C57BL/6 infection model, a significant proportion (30-40%) of the T. cruzi-specific CD8+ T cell response targets two immunodominant TS epitopes, TSKb18 and TSKb20. However, both TS-specific CD8+ T cell responses are dispensable for immune control, and TS-based vaccines have no demonstrable impact on parasite persistence, a determinant of disease. Besides TS, the specificity and protective capacity of CD8+ T cells that mediate immune control of T. cruzi infection are unknown. With the goal of identifying alternative CD8+ T cell targets, we designed and screened a representative set of genome-wide, in silico-predicted epitopes. Our screen identified a previously uncharacterized, to our knowledge, T cell epitope MUCKb25, found within mucin family proteins, the third most expanded large gene family in T. cruzi. The MUCKb25-specific response was characterized by delayed kinetics, relative to TS-specific responses, and extensive cross-reactivity with a large number of endogenous epitope variants. Similar to TS-specific responses, the MUCKb25 response was dispensable for control of the infection, and vaccination to generate MUCK-specific CD8+ T cells failed to confer protection. The lack of protection by MUCK vaccination was partly attributed to the fact that MUCKb25-specific T cells exhibit limited recognition of T. cruzi-infected host cells. Overall, these results indicate that the CD8+ T cell compartment in many T. cruzi-infected mice is occupied by cells with minimal apparent effector potential.

Citing Articles

: Genomic Diversity and Structure.

Herreros-Cabello A, Callejas-Hernandez F, Girones N, Fresno M Pathogens. 2025; 14(1).

PMID: 39861022 PMC: 11768934. DOI: 10.3390/pathogens14010061.


Signature of cardiac alterations in early and late chronic infections with Trypanosoma cruzi in mice.

Arias-Argaez B, Dzul-Huchim V, Haro-Alvarez A, Rosado-Vallado M, Villanueva-Lizama L, Cruz-Chan J PLoS One. 2023; 18(10):e0292520.

PMID: 37797045 PMC: 10553825. DOI: 10.1371/journal.pone.0292520.

References
1.
Rosenberg C, Martin D, Tarleton R . CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol. 2010; 185(1):560-8. PMC: 3784248. DOI: 10.4049/jimmunol.1000432. View

2.
Katae M, Miyahira Y, Takeda K, Matsuda H, Yagita H, Okumura K . Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy. Infect Immun. 2002; 70(9):4833-40. PMC: 128276. DOI: 10.1128/IAI.70.9.4833-4840.2002. View

3.
Wizel B, Nunes M, Tarleton R . Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. J Immunol. 1998; 159(12):6120-30. View

4.
de Pablos L, Osuna A . Multigene families in Trypanosoma cruzi and their role in infectivity. Infect Immun. 2012; 80(7):2258-64. PMC: 3416482. DOI: 10.1128/IAI.06225-11. View

5.
Lidani K, Andrade F, Bavia L, Damasceno F, Beltrame M, Messias-Reason I . Chagas Disease: From Discovery to a Worldwide Health Problem. Front Public Health. 2019; 7:166. PMC: 6614205. DOI: 10.3389/fpubh.2019.00166. View